These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16731834)

  • 1. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
    Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
    Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
    Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
    J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type.
    Ralph EC; Sun S
    Biochemistry; 2009 Mar; 48(11):2514-21. PubMed ID: 19187021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.
    Arden C; Trainer A; de la Iglesia N; Scougall KT; Gloyn AL; Lange AJ; Shaw JA; Matschinsky FM; Agius L
    Diabetes; 2007 Jul; 56(7):1773-82. PubMed ID: 17389332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucokinase mutations in young children with hyperglycemia.
    Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
    Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase.
    Tiedge M; Richter T; Lenzen S
    Arch Biochem Biophys; 2000 Mar; 375(2):251-60. PubMed ID: 10700381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and pathomorphological characteristics of a novel mutant mouse model for maturity-onset diabetes of the young type 2 (MODY 2).
    van Bürck L; Blutke A; Kautz S; Rathkolb B; Klaften M; Wagner S; Kemter E; Hrabé de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E512-23. PubMed ID: 19952346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation.
    Negahdar M; Aukrust I; Johansson BB; Molnes J; Molven A; Matschinsky FM; Søvik O; Kulkarni RN; Flatmark T; Njølstad PR; Bjørkhaug L
    Biochim Biophys Acta; 2012 Nov; 1822(11):1705-15. PubMed ID: 22820548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis.
    Davis EA; Cuesta-Muñoz A; Raoul M; Buettger C; Sweet I; Moates M; Magnuson MA; Matschinsky FM
    Diabetologia; 1999 Oct; 42(10):1175-86. PubMed ID: 10525657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence.
    Zelent B; Odili S; Buettger C; Shiota C; Grimsby J; Taub R; Magnuson MA; Vanderkooi JM; Matschinsky FM
    Biochem J; 2008 Jul; 413(2):269-80. PubMed ID: 18370929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
    Fujimoto Y; Torres TP; Donahue EP; Shiota M
    Diabetes; 2006 Sep; 55(9):2479-90. PubMed ID: 16936196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.
    Bourbonais FJ; Chen J; Huang C; Zhang Y; Pfefferkorn JA; Landro JA
    Biochem J; 2012 Feb; 441(3):881-7. PubMed ID: 22044397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
    Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
    Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients.
    Lopez AP; Foscaldi SA; Pérez MS; Krochik G; Rodríguez M; Traversa M; Puchulu FM; Hirschler V; Bergada I; Frechtel GD
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):391-4. PubMed ID: 19358091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
    Loomba-Albrecht LA; Jame M; Bremer AA
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of E339K mutated human glucokinase reveals changes in the ATP binding site.
    Liu Q; Shen Y; Liu S; Weng J; Liu J
    FEBS Lett; 2011 Apr; 585(8):1175-9. PubMed ID: 21420961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.